Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic

Elisabet Van Loon1, Baptiste Lamarthée2, Henriette de Loor3

  • 1Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium; Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.

Insights

Kidney transplant rejection involves immune cell changes detectable in blood. This study reveals specific immune activation pathways in peripheral blood leukocytes during kidney allograft pathology, offering targets for new therapies.

Area of Science:

  • Transplantation immunology
  • Molecular diagnostics
  • Genomics

Background:

  • Kidney transplant injury is linked to molecular changes in kidney tissue, primarily immune cell activation and infiltration.
  • The reflection of these processes in circulating immune cells, targeted by immunosuppressants, remains poorly understood.

Purpose of the Study:

  • To investigate molecular alterations in peripheral blood immune cells during kidney transplant rejection.
  • To correlate blood molecular changes with kidney allograft biopsy findings.
  • To identify immune activation pathways in peripheral blood leukocytes despite immunosuppression.

Main Methods:

  • RNA-sequencing of 384 peripheral blood samples from kidney transplant patients.
  • Transcriptomic analysis of 224 kidney allograft biopsies.
  • Single-cell RNA sequencing (scRNASeq) of seven kidney allograft biopsies and peripheral blood immune cells.
  • Validation in independent cohorts.

Main Results:

  • Differentially expressed genes in rejection vs. no rejection blood samples showed upregulated glucocorticoid receptor and nucleotide oligomerization domain-like receptor signaling pathways.
  • Antibody-mediated rejection (ABMR) pathways were strongly immune-specific; T cell-mediated rejection pathways were less immune-related.
  • Polyomavirus infection showed upregulated mitochondrial dysfunction and interferon signaling pathways.
  • Blood findings were consistently mirrored in kidney allograft biopsy transcriptomics.
  • scRNASeq confirmed that consistently overexpressed genes in ABMR were expressed by infiltrating leukocytes in both blood and biopsy.

Conclusions:

  • Immune activation pathways are present in peripheral blood leukocytes at the time of kidney allograft pathology, even with strong immunosuppressants.
  • Findings provide a molecular framework for understanding kidney transplant rejection and developing future therapeutic interventions.